107 related articles for article (PubMed ID: 2109270)
1. Evidence for the involvement of corticotropin-releasing factor in the inhibition of gonadotropin release induced by hyperprolactinemia.
Kooy A; de Greef WJ; Vreeburg JT; Hackeng WH; Ooms MP; Lamberts SW; Weber RF
Neuroendocrinology; 1990 Mar; 51(3):261-6. PubMed ID: 2109270
[TBL] [Abstract][Full Text] [Related]
2. In vivo release of dopamine, luteinizing hormone-releasing hormone and thyrotropin-releasing hormone in male rats bearing a prolactin-secreting tumor.
Voogt JL; de Greef WJ; Visser TJ; de Koning J; Vreeburg JT; Weber RF
Neuroendocrinology; 1987 Aug; 46(2):110-6. PubMed ID: 3114662
[TBL] [Abstract][Full Text] [Related]
3. LH-RH and dopamine levels in hypophysial stalk plasma and their relationship to plasma gonadotrophins and prolactin levels in male rats bearing a prolactin- and adrenocorticotrophin-secreting pituitary tumor.
Weber RF; de Greef WJ; de Koning J; Vreeburg JT
Neuroendocrinology; 1983; 36(3):205-10. PubMed ID: 6300718
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of luteinizing hormone during hyperprolactinemia: response to central administration of antagonists of corticotropin-releasing factor.
de Greef WJ; Ooms MP; Vreeburg JT; Weber RF
Neuroendocrinology; 1995 Jan; 61(1):19-26. PubMed ID: 7731494
[TBL] [Abstract][Full Text] [Related]
5. Effects of experimentally-induced chronic hyperprolactinemia on testosterone and gonadotropin levels in male rats and mice.
Bartke A; Smith MS; Michael SD; Peron FG; Dalterio S
Endocrinology; 1977 Jan; 100(1):182-6. PubMed ID: 830537
[TBL] [Abstract][Full Text] [Related]
6. Effect of prolactin on the secretion of hypothalamic GnRH and pituitary gonadotropins.
Koike K; Miyake A; Aono T; Sakumoto T; Ohmichi M; Yamaguchi M; Tanizawa O
Horm Res; 1991; 35 Suppl 1():5-12. PubMed ID: 1752606
[TBL] [Abstract][Full Text] [Related]
7. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
Rivier C; Vale W
J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
[TBL] [Abstract][Full Text] [Related]
8. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
Tresguerres JA; Esquifino AI
Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
[TBL] [Abstract][Full Text] [Related]
9. Effects of a prolactin- and adrenocorticotropin-secreting tumor on gonadotropin levels and accessory sex organ weights in adult male rats: a possible role of the adrenals.
Weber RF; Ooms MP; Vreeburg JT
Endocrinology; 1982 Aug; 111(2):412-7. PubMed ID: 6284478
[TBL] [Abstract][Full Text] [Related]
10. Temporal relationships between the circadian rhythmicity in plasma levels of pituitary hormones and in hypothalamic concentrations of releasing factors.
Szafarczyk A; Hery M; Laplante E; Ixart G; Assenmacher I; Kordon C
Neuroendocrinology; 1980 Jun; 30(6):369-76. PubMed ID: 6247669
[TBL] [Abstract][Full Text] [Related]
11. Effect of passive immunization against corticotropin-releasing factor (CRF) on the postadrenalectomy changes of CRF binding sites in the rat anterior pituitary gland.
Grino M; Guillaume V; Castanas E; Boudouresque F; Conte-Devolx B; Oliver C
Neuroendocrinology; 1987 Jun; 45(6):492-7. PubMed ID: 3039393
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin secretion in rats bearing a prolactin-secreting pituitary tumor: effects of naloxone administration.
Lamberts SW; Zuiderwijk JM; Bons EG; Uitterlinden P; de Jong FH
Fertil Steril; 1981 May; 35(5):557-62. PubMed ID: 6785115
[TBL] [Abstract][Full Text] [Related]
13. Onset of glucocorticoid responsiveness of anterior pituitary corticotrophs during development is scheduled by corticotropin-releasing factor.
Grino M; Burgunder JM; Eskay RL; Eiden LE
Endocrinology; 1989 Jun; 124(6):2686-92. PubMed ID: 2524376
[TBL] [Abstract][Full Text] [Related]
14. The effect of hyperprolactinemia produced by transplantable pituitary MtTW15 tumor cells in male rats on hypothalamic luteinizing hormone-releasing hormone release in vitro: effects of naloxone and K+.
Kalra PS; Kalra SP
Endocrinology; 1987 Jul; 121(1):310-5. PubMed ID: 3297642
[TBL] [Abstract][Full Text] [Related]
15. Effects of the new prolactin-producing tumour 7315b on gonadotrophin secretion in adult male and female rats.
Kooy A; Weber RF; Ooms MP; Vreeburg JT
J Endocrinol; 1989 Feb; 120(2):261-8. PubMed ID: 2494282
[TBL] [Abstract][Full Text] [Related]
16. Suppression of pulsatile LH secretion, pituitary GnRH receptor content and pituitary responsiveness to GnRH by hyperprolactinemia in the male rat.
Fox SR; Hoefer MT; Bartke A; Smith MS
Neuroendocrinology; 1987 Oct; 46(4):350-9. PubMed ID: 2823160
[TBL] [Abstract][Full Text] [Related]
17. Examination of prolactin and pituitary-adrenal axis components as intervening variables in the adrenalectomy-induced inhibition of gonadotropin response to castration.
Ringstrom SJ; Schwartz NB
Endocrinology; 1984 Mar; 114(3):880-7. PubMed ID: 6321145
[TBL] [Abstract][Full Text] [Related]
18. Endogenous human growth hormone (GH) modulates the effect of gonadotropin-releasing hormone on pituitary function and the gonadotropin response to the negative feedback effect of testosterone in adult male transgenic mice bearing human GH gene.
Chandrashekar V; Bartke A; Wagner TE
Endocrinology; 1988 Dec; 123(6):2717-22. PubMed ID: 3143542
[TBL] [Abstract][Full Text] [Related]
19. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
[TBL] [Abstract][Full Text] [Related]
20. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
Dallman MF; Makara GB; Roberts JL; Levin N; Blum M
Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
